Mesenbio

Business Services · United Kingdom · 1-10 Employees

View Company Info for Free

Overview

Headquarters

York, United Kingdom

Revenue

<$5 Million

Industry

Business Services Healthcare Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Mesenbio

Mesenbio is a preclinical stage biopharmaceutical company from the University of York. Our Cell Line Extracellular Vesicle Release (CLEVR) platform enables us to pursue a varied therapeutic pipeline by addressing the most prevalent bottleneck in extracellular vesicle therapeutics: consistency. We leverage our platform to produce a consistent, endless supply of therapeutically exciting extracellular vesicles. Our aim is to transform medicine by unlocking extracellular vesicles as a novel treatment modality.Explore more
Mesenbio's Social MediaPopular SearchesMesenbioSIC Code 87,873NAICS Code 54,541Show more

Mesenbio Org Chart

PhoneEmail
FR
United Kingdom flag for contact location.

Angel Investor

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Mesenbio your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Mesenbio

Compare insights from companies similar to Mesenbio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Mesenbio

<$5M
1-10
Private
<$5M
2021
FR
Faezeh RakhshanAngel Investor
<$5M
11-50
Private
-
2017
YA
Yash AgrawalCancer Care Manager
<$5M
1-10
Private
-
2017
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
2017
N/A
<$5M
11-50
Private
-
2019
N/A
<$5M
1-10
Private
-
-
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Mesenbio is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Mesenbio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Mesenbio.

Mesenbio financials insights

Gather financial insights about Mesenbio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2024

Other Financing Round

$1.8M

See All Mesenbio's Financials Insights

Mesenbio Tech Stack

A closer look at the technologies used by Mesenbio

Top Business Services Companies

Frequently Asked Questions Regarding Mesenbio

What is Mesenbio's official website?
Mesenbio's official website is www.mesenbio.net
What is Mesenbio's Revenue?
Mesenbio's revenue is <$5 Million
What is Mesenbio's SIC code?
Mesenbio's SIC: 87,873
What is Mesenbio's NAICS code?
Mesenbio's NAICS: 54,541
How many employees does Mesenbio have?
Mesenbio has 1-10 employees
What industry does Mesenbio belong to?
Mesenbio is in the industry of: Business Services, Healthcare Services, Research & Development
What is Mesenbio competition?
Mesenbio top competitors include: Tmmune, CanCertain, Agamemnon Epenetos, Testavec
What technology does Mesenbio use?
Some of the popular technologies that Mesenbio uses are: Squarespace Online Stores, Adobe Typekit, Vimeo, Squarespace
What does Mesenbio do?

Mesenbio is a preclinical stage biopharmaceutical company from the University of York. Our Cell Line Extracellular Vesicle Release (CLEVR) platform enables us to pursue a varied therapeutic pipeline by addressing the most prevalent bottleneck in extracellular vesicle therapeutics: consistency. We leverage our platform to produce a consistent, endle... ss supply of therapeutically exciting extracellular vesicles. Our aim is to transform medicine by unlocking extracellular vesicles as a novel treatment modality.Read More

What are Mesenbio social media links?
Mesenbio Linkedin page
Who invested in Mesenbio?
Mesenbio has 2 investors including Innovate UK and NG Bio.
Is Mesenbio a public company?
Mesenbio is private company therefore does not currently have an official ticker symbol
See more information about Mesenbio

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.